Unilife Corp  

(Public, NASDAQ:UNIS)   Watch this stock  
Find more results for UNIS
2.47
+0.01 (0.41%)
Aug 28 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.41 - 2.51
52 week 2.20 - 5.80
Open 2.43
Vol / Avg. 347,054.00/747,511.00
Mkt cap 252.88M
P/E     -
Div/yield     -
EPS -0.69
Shares 102.80M
Beta 1.06
Inst. own 40%
Sep 8, 2014
Q4 2014 Unilife Corp Earnings Release (Estimated) Add to calendar
Jun 2, 2014
Unilife Corp at Jefferies Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -1092.48% -2303.97%
Operating margin -1034.71% -2225.96%
EBITD margin - -1880.10%
Return on average assets -71.81% -83.87%
Return on average equity -262.47% -159.30%
Employees 159 -
CDP Score - -

Address

250 Cross Farm Lane
YORK, PA 17406
United States - Map
+1-717-3843400 (Phone)
+1-717-3843401 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Unilife Corporation (Unilife) is a developer, manufacturer and supplier of injectable drugs delivery systems. The Company manufactures and supplies its devices to pharmaceutical companies in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user. The Company's technology platforms cover six device categories: Prefilled Syringes, Drug Reconstitution Delivery Systems, Auto-Injectors, Wearable Injectors, Ocular Delivery Systems and Delivery Systems.

Officers and directors

Alan D. Shortall Chairman of the Board, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Ramin Mojdehbakhsh Ph.D. President, Chief Operating Officer
Age: 51
Bio & Compensation  - Reuters
Slavko James Joseph Bosnjak Deputy Vice Chairman of the Board, Lead Independent Director
Age: 64
Bio & Compensation  - Reuters
Dennis P. Pyers Interim Chief Financial Officer, Chief Accounting Officer, Vice President, Controller
Age: 53
Bio & Compensation  - Reuters
John Ryan J.D. Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation  - Reuters
Mark V. Iampietro Vice President - Quality and Regulatory Affairs
Age: 60
Bio & Compensation  - Reuters
J. Christopher Naftzger J.D., Vice President - Legal Affairs
Age: 46
Bio & Compensation  - Reuters
Jeff Carter Non-Executive Director, Investor Relations Support
Bio & Compensation  - Reuters
William Galle Independent Non-Executive Director
Age: 74
Bio & Compensation  - Reuters
John M. Lund Independent Non-Executive Director
Age: 47
Bio & Compensation  - Reuters